피부 알레르기 치료제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Skin Allergy Therapeutics Market size is expected to reach USD 17.44 Billion in 2034 from USD 6.67 Billion (2025) growing at a CAGR of 11.28% during 2026-2034.

The Global Skin Allergy Therapeutics Market is witnessing consistent growth due to rising incidence of allergic skin conditions such as dermatitis and urticaria. Increasing environmental pollution and lifestyle changes are contributing to higher allergy cases. Growing awareness about dermatological treatments is supporting market expansion.

Key growth drivers include advancements in antihistamines, corticosteroids, and biologic therapies. Pharmaceutical companies are focusing on targeted and long-lasting treatment solutions. Rising healthcare spending and improved access to dermatology services are further strengthening demand. Additionally, increased research into immune-mediated skin conditions is contributing to product innovation.

Looking ahead, the market is expected to benefit from personalized treatment approaches and safer drug formulations. Emerging markets expanding dermatology care services will create new growth opportunities. Companies are investing in advanced topical and systemic therapies. As allergy awareness rises globally, the Global Skin Allergy Therapeutics Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Indications

• Urticaria
• Anaphylaxis
• Conjunctivitis
• Drug Allergy
• Allergic Asthma
• Allergic Rhinitis
• Others

By Type

• Patch
• Intradermal
• Prick
• Others

By End-user

• Hospitals & Clinics
• Diagnostic Centers
• Others

COMPANIES PROFILED

• Stallergenes Greer, Thermo Fisher Scientific, Siemens Healthcare, Omega Diagnostics, JDP Therapeutics Inc, Hycor Biomedical, HOB Biotech Group, Genentech Inc, Hitachi Chemical Diagnostics, Danaher Corporation, bioMrieux, Lincoln Diagnostics
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET: BY INDICATIONS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Indications
• 4.2. Urticaria Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Anaphylaxis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Conjunctivitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Drug Allergy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Allergic Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Allergic Rhinitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Patch Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Intradermal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Prick Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Indications
  • 7.2.2 By Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Indications
  • 7.3.2 By Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Indications
  • 7.4.2 By Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Indications
  • 7.5.2 By Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Indications
  • 7.6.2 By Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SKIN ALLERGY THERAPEUTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Stallergenes Greer
  • 9.2.2 Thermo Fisher Scientific
  • 9.2.3 Siemens Healthcare
  • 9.2.4 Omega Diagnostics
  • 9.2.5 JDP Therapeutics Inc
  • 9.2.6 Hycor Biomedical
  • 9.2.7 HOB Biotech Group
  • 9.2.8 Genentech Inc
  • 9.2.9 Hitachi Chemical Diagnostics
  • 9.2.10 Danaher Corporation
  • 9.2.11 BioMAfA(C)Rieux
  • 9.2.12 Lincoln Diagnostics